EMAIL THIS PAGE TO A FRIEND

Acta tropica

Characterization of a Trichinella spiralis 31 kDa protein and its potential application for the serodiagnosis of trichinellosis.


PMID 25447831

Abstract

The Trichinella spiralis 31 kDa protein (Ts31) was screened from the excretory-secretory (ES) proteins of muscle larvae (ML) by immunoproteomics using serum from mice infected with T. spiralis at 18 days post infection (dpi). The aim of this study was to characterize the Ts31 protein and to evaluate the potential of the recombinant Ts31 protein (rTs31) for serodiagnosis of human trichinellosis. Ts31 gene was cloned and rTs31 was produced in an E. coli expression system. An anti-rTs31serum recognized the native protein migrating in a 25-55 kDa range by Western blotting of ML crude or ES antigens. Expression of Ts31 gene was observed at all developmental stages of T. spiralis (adult worms, newborn larvae, pre-encapsulated larvae and ML). An immunolocalization analysis identified Ts31 in the cuticle and stichocytes of the parasite. The sensitivity of rTs31-ELISA and ES antigen ELISA for detecting anti-Trichinella IgG antibodies in sera of patients with trichinellosis was 97.83% (45/46) and 86.78% (39/46), respectively (P>0.05); The specificity of rTs31-ELISA was 99.13% (114/115), which was significantly higher than 85.22% (98/115) of ES antigen ELISA (P<0.01). The rTs31 protein of T. spiralis could be considered as a potential diagnostic antigen for trichinellosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D5905
3,3′-Diaminobenzidine tetrahydrochloride, tablet, 10 mg substrate per tablet
C12H14N4 · 4HCl
P5412
o-Phenylenediamine, tablet, 20 mg substrate per tablet
C6H8N2
P9029
o-Phenylenediamine, Peroxidase substrate, ≥98.0%, powder
C6H8N2
78410
o-Phenylenediamine, suitable for fluorescence, ≥99.0% (NT)
C6H8N2
P23938
o-Phenylenediamine, flaked, 99.5%
C6H8N2
694975
o-Phenylenediamine, sublimed, ≥99%
C6H8N2
P6662
o-Phenylenediamine dihydrochloride, tablet, 1 mg substrate per tablet
C6H8N2 · 2HCl
P6787
o-Phenylenediamine dihydrochloride, tablet, 2 mg substrate per tablet
C6H8N2 · 2HCl
P8806
o-Phenylenediamine dihydrochloride, tablet, 3 mg substrate per tablet
C6H8N2 · 2HCl
P8787
o-Phenylenediamine dihydrochloride, tablet, 4 mg substrate per tablet
C6H8N2 · 2HCl
P3804
o-Phenylenediamine dihydrochloride, tablet, 5 mg substrate per tablet
C6H8N2 · 2HCl
P6912
o-Phenylenediamine dihydrochloride, tablet, 5 mg substrate per tablet
C6H8N2 · 2HCl
P8287
o-Phenylenediamine dihydrochloride, tablet, 10 mg substrate per tablet
C6H8N2 · 2HCl
P4664
o-Phenylenediamine dihydrochloride, tablet, 15 mg substrate per tablet
C6H8N2 · 2HCl
P7288
o-Phenylenediamine dihydrochloride, tablet, 20 mg substrate per tablet
C6H8N2 · 2HCl
P8412
o-Phenylenediamine dihydrochloride, tablet, 30 mg substrate per tablet
C6H8N2 · 2HCl
P1063
o-Phenylenediamine dihydrochloride, tablet, 60 mg substrate per tablet
C6H8N2 · 2HCl
P1526
o-Phenylenediamine dihydrochloride, peroxidase substrate
C6H8N2 · 2HCl